PIINDBSEPI Industries LtdMinimalNeutral
Announced Tue, 19 May · 21:42 IST

Re-appointment of M/s K.G. Goyal & Co. as Cost Auditors of the Company for the financial year 2026-27

Exceptional ItemCompliance View source PDF

PIIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-11.8%1-day move
₹3120.40
prior close
₹2950.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.8-1.4-2.0-0.2-11.8-10.9-8.8-8.9-8.7-13.2-10.1-10.0-14.7
Up moveDown movePending
AI summary

PI Industries reported audited standalone financials for FY2026 with total income of Rs 64,904 million, profit before tax of Rs 17,989 million, and profit after tax of Rs 14,348 million. EPS stood at Rs 94.57. The Board recommended a final dividend of Rs 10 per share (1000% on Re 1 face value), taking total dividend for the year to Rs 15 per share including the Rs 5 interim already paid. Exceptional items included Rs 1,100 million impairment provision for PI Health Sciences subsidiary and Rs 223 million related to new labour codes. The Board re-appointed M/s K.G. Goyal & Co. as Cost Auditors for FY2026-27. Key governance changes: Ms. Lisa Brown designated Lead Independent Director, Mr. Rajnish Sarna resigned as Joint MD and continues as Non-Executive Director, Mr. Arvind Singhal retiring at AGM, Dr. Marco Busch designated Senior Management, and Dr. Atul Kumar Gupta appointed as Whole-time Director. Three director re-appointments proposed for shareholder approval.

Likely market impact

Strong financial performance with clean audit opinion supports shareholder confidence. Increased total dividend to Rs 15/share signals management's optimism. Multiple leadership and board changes reflect governance refresh. The Rs 1,100 million impairment on subsidiary is non-cash but worth monitoring.